EUPRAXIA PHARMACEUTICALS INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $639.60K 40-F · filed 2026-03-13 | |
| 2024-12-31 | $25.25K 40-F · filed 2026-03-13 | |
| 2023-12-31 | $30.06K 40-F · filed 2025-03-20 |